As of June 30, 2026, Ocumetics Technology Corp carries a market capitalization of 60.49M, placing it among publicly traded companies globally. Its enterprise value stands at 64.71M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 60.49M |
| Enterprise Value | 64.71M |
As of June 30, 2026, Ocumetics Technology Corp has 134.41M shares outstanding.
| Shares Outstanding | 134.41M |
These figures are as of June 30, 2026.
| PB Ratio | -13.78 |
| P/TBV Ratio | -12.20 |
| P/FCF Ratio | -20.91 |
| P/OCF Ratio | -21.73 |
As of June 30, 2026, Ocumetics Technology Corp maintains a current ratio of 0.03, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -98.20, indicating conservative leverage, while an interest coverage ratio of -4.53 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.03 |
| Quick Ratio | 0.02 |
| Debt / Equity | -98.20 |
| Debt / EBITDA | -0.55 |
| Interest Coverage | -4.53 |
These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -816.12, reflecting losses generated across the asset base.
| Return on Assets (ROA) | -816.12 |
As of the close on October 20, 2026, Ocumetics Technology Corp's stock has declined approximately 64.29% over the past 52 weeks. The 50-day moving average sits at 0.47, while the 200-day moving average is 0.53.
| 52-Week Price Change | -64.29% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 0.53 |
Over the twelve months ended June 30, 2026, Ocumetics Technology Corp generated - - in revenue and converted that into -7.57M in net income, yielding earnings per share of -0.06. EBITDA reached -7.79M, while operating income came in at -4.48M.
| Operating Income | -4.48M |
| Pretax Income | -7.57M |
| Net Income | -7.57M |
| EBITDA | -7.79M |
| EBIT | -7.94M |
| Earnings Per Share (EPS) | -0.06 |
As of June 30, 2026, Ocumetics Technology Corp holds 88,743.00 in cash and equivalents against 4.31M in total debt, resulting in a net debt position of 4.22M. Total book value stands at -4.39M, with working capital of -4.59M providing operational flexibility.
| Cash & Cash Equivalents | 88,743.00 |
| Total Debt | 4.31M |
| Net Debt | 4.22M |
| Equity (Book Value) | -4.39M |
| Book Value Per Share | -0.03 |
| Working Capital | -4.59M |
Ocumetics Technology Corp produced -2.66M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -103,941.00 in capital expenditures, free cash flow totaled -2.77M - equivalent to -0.02 per share.
| Operating Cash Flow | -2.66M |
| Capital Expenditures | -103,941.00 |
| Free Cash Flow | -2.77M |
| FCF Per Share | -0.02 |
These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -4.78: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -4.04, meaning Ocumetics Technology Corp raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -4.04 |
| FCF Yield | -4.78 |
As of June 30, 2026, Ocumetics Technology Corp has an Altman Z-Score of -278.74, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -278.74 |
Already premium?